Blood and Immunity Practice Questions

Q: A 45-year-old patient with chronic anemia presents with fatigue, dyspnea, and visible cyanosis. Recent blood tests show hemoglobin of 7 g/dL. Which of the following best explains the presence of cyanosis in this patient?

Increased deoxyhemoglobin concentration. ***Increased deoxyhemoglobin concentration*** - Cyanosis is defined as visible bluish discoloration of skin and mucous membranes that occurs when **≥5 g/dL of deoxygenated hemoglobin** is present in capillary blood. - By definition, cyanosis requires a sufficient **absolute amount of deoxyhemoglobin**, not just a low total hemoglobin. - In this patient with Hb 7 g/dL, if cyanosis is indeed present, it indicates that despite the anemia, there is still sufficient deoxyhemoglobin concentration to cross the threshold for visible cyanosis, likely due to severe hypoxemia or additional cardiopulmonary pathology. - **Important note:** Severe anemia alone typically does NOT cause cyanosis (patients appear pale); the presence of cyanosis here suggests a coexisting condition causing increased deoxyhemoglobin. *Decreased oxygen-carrying capacity of blood* - While this accurately describes the pathophysiology of anemia (reduced total hemoglobin), it does **not explain cyanosis**. - In fact, decreased oxygen-carrying capacity in severe anemia typically **prevents cyanosis** because there is insufficient total hemoglobin to generate the 5 g/dL deoxyhemoglobin threshold needed for visible cyanosis. - Classic teaching: "Anemic patients do not become cyanotic; they become pale." *Methemoglobinemia* - This condition involves hemoglobin oxidized to the ferric state (Fe³⁺), which cannot bind oxygen and causes a characteristic slate-gray or brownish cyanosis. - While methemoglobinemia can coexist with anemia, there is no indication in the clinical scenario (no exposure history, no "chocolate-brown" blood description) to suggest this diagnosis. *Peripheral vasoconstriction* - Peripheral vasoconstriction reduces blood flow to the skin, causing **pallor or a mottled appearance**, not true cyanosis. - Cyanosis is specifically due to increased deoxyhemoglobin in capillary blood, not reduced perfusion alone.

Q: Which of the following best describes the function of hemoglobin in the blood?

Transport of oxygen. ***Transport of oxygen*** - **Hemoglobin** is a **metalloprotein** in red blood cells crucial for binding and transporting **oxygen** from the lungs to tissues. - Its structure, containing **heme groups** with iron, allows for efficient reversible binding of oxygen molecules. *Buffering blood pH* - While hemoglobin does have some minor buffering capacity, contributing to a stable **blood pH**, it is not its primary function. - The main systems for pH regulation are the **bicarbonate buffer system** and renal mechanisms. *Clot formation* - **Clot formation** is primarily mediated by **platelets** and a complex cascade of **coagulation factors** in the plasma. - Hemoglobin is not directly involved in the process of hemostasis or clot formation. *Immune response* - The **immune response** is primarily carried out by **white blood cells (leukocytes)**, antibodies, and the complement system. - Hemoglobin does not play a role in recognizing or fighting pathogens.

Q: A blood grouping test shows clumping with Anti-A serum, clumping with Anti-B serum, and no clumping in the control. What blood group does this indicate?

AB. ***AB*** - The results show **clumping with both Anti-A and Anti-B serum**, indicating the presence of both A and B antigens on the red blood cells. - The absence of clumping in the control confirms that the **agglutination with Anti-A and Anti-B is due to specific antigen-antibody reactions**, not nonspecific agglutination. - Blood group AB individuals have both A and B antigens on their RBCs and no anti-A or anti-B antibodies in their serum. *A* - Blood group A would show **clumping with Anti-A serum only** and no clumping with Anti-B serum. - This is incorrect because the sample shows clumping with both antisera. *B* - Blood group B would show **clumping with Anti-B serum only** and no clumping with Anti-A serum. - This is incorrect because the sample shows clumping with both antisera. *O* - Blood group O would show **no clumping with either Anti-A or Anti-B serum**, as it lacks both A and B antigens. - This is incorrect because the sample clearly shows clumping with both Anti-A and Anti-B sera.

Q: What is the lower limit of normal hemoglobin (Hb) value for a non-pregnant adult female in grams per deciliter (gm/dl)?

12 gm/dl. ***12 gm/dl*** - The **World Health Organization (WHO)** defines anemia in non-pregnant adult females as a hemoglobin level below **12 gm/dl** - This threshold represents the **lower limit of normal** for this population - Below this value indicates clinically significant anemia requiring evaluation and potential treatment *10 gm/dl* - A hemoglobin level of **10 gm/dl** is **below the normal range** and indicates **moderate anemia** in a non-pregnant adult female - This is **2 gm/dl below the lower limit** and would require investigation for causes such as iron deficiency, chronic disease, or blood loss - Not the lower limit of normal, but a pathological value *11 gm/dl* - A hemoglobin level of **11 gm/dl** indicates **mild anemia** in a non-pregnant adult female - This is **1 gm/dl below the WHO cutoff** for defining anemia in this population - Note: This value (11 gm/dl) is the lower limit for **pregnant females**, not non-pregnant females *15.8 gm/dl* - A hemoglobin level of **15.8 gm/dl** is **well within the normal range** for a non-pregnant adult female - This value is toward the **upper end of normal** (typical range: 12-16 gm/dl for females) - This cannot be a lower limit as it exceeds the normal range minimum by nearly 4 gm/dl

Q: Which pathway is primarily initiated by tissue factor in the coagulation process?

Extrinsic pathway. ***In vivo pathway*** - Tissue factor is primarily involved in the **extrinsic pathway** of coagulation, which activates **thrombin** and leads to the formation of fibrin in response to tissue injury [1]. - It is expressed on the surface of **vascular cells**, interacting with factor VII to initiate the clotting cascade during **hemostasis** [1]. *In vitro pathway* - This refers to coagulation processes studied in a **controlled laboratory** environment, not involving tissue factor as it predominantly relates to the **extrinsic pathway**. - In vitro conditions may not mimic the complex physiological responses seen in vivo. *Intrinsic pathway* - This pathway is activated by contact with negatively charged surfaces and does not require **tissue factor**, instead involving factors like **XII, XI, IX, and VIII**. - It primarily takes place in the **test tube** setting rather than in a physiological context. *Contact pathway* - This term generally refers to the activation of the intrinsic pathway via the **contact with an artificial surface**, which again does not involve **tissue factor**. - It is not a primary pathway for activating coagulation in normal **physiological** processes. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 126-128.

Q: What does tissue factor activate?

Proconvertin. ***Preaccelerin*** - Tissue factor is known to activate **factor VII**, which is also referred to as **preaccelerin**, leading to the initiation of the extrinsic pathway of the coagulation cascade [1]. - This activation is crucial for the conversion of **prothrombin to thrombin**, facilitating clot formation [1]. *Labile factor* - Labile factor is another name for **factor V**, which is not directly activated by tissue factor but is involved in later stages of the coagulation pathway. - It is more relevant in the **prothrombinase complex**, which is formed after tissue factor activation. *Prothrombin* - Prothrombin is the **substrate** that tissue factor helps to convert, not an immediate product of tissue factor activation. - The activation of prothrombin requires **thrombin**, which is generated as a downstream effect of tissue factor activation [1]. *Hageman factor* - Hageman factor, also known as **factor XII**, plays a role in the intrinsic pathway and is activated by contact with collagen or glass, not directly by tissue factor. - Tissue factor primarily activates **factor VII**, which does not involve Hageman factor in the coagulation cascade [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 126-130.

Q: Which test is used for both intrinsic and common clotting pathways?

Partial thromboplastin time. ***Partial thromboplastin time*** - The **partial thromboplastin time (PTT)** assay evaluates both the **intrinsic** and **common pathways** of coagulation [1], crucial for diagnosing bleeding disorders. - It is used to monitor patients on **heparin therapy**, assessing factors including **VIII, IX, XI, and XII**. *Ristocetin agglutination test* - This test specifically assesses **von Willebrand factor** function, reflecting defects in platelet adhesion rather than a comprehensive assessment of clotting pathways. - It does not evaluate intrinsic or common pathways effectively, focusing primarily on **primary hemostasis**. *FDPs* - Fibrin degradation products (FDPs) are markers of clot breakdown rather than direct tests of the intrinsic or common pathways of coagulation. - Elevated FDPs indicate **disease states** like disseminated intravascular coagulation (DIC), not functioning coagulation pathways. *Thrombin time* - Thrombin time measures the conversion of **fibrinogen to fibrin**, assessing the **final step** in the coagulation cascade, primarily related to the **common pathway**. - It does not evaluate the intrinsic pathway, making it unsuitable for assessing both pathways comprehensively. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 128-130.

Q: Which type of white blood cell is responsible for 'remembering' previous encounters with pathogens?

Lymphocytes. ***Correct: Lymphocytes*** - **B-lymphocytes** and **T-lymphocytes** are central to adaptive immunity, which includes immunological memory. - Upon primary exposure to a pathogen, some lymphocytes differentiate into **memory cells** that can quickly respond to subsequent encounters. *Incorrect: Basophils* - **Basophils** are involved in allergic reactions and inflammatory responses, releasing histamine and other mediators. - They do not possess the ability to "remember" pathogens. *Incorrect: Eosinophils* - **Eosinophils** are primarily involved in defense against parasites and in allergic reactions. - They do not play a role in immunological memory. *Incorrect: Neutrophils* - **Neutrophils** are phagocytic cells that are part of the innate immune system, acting as the first responders to infection. - While crucial for immediate defense, they do not retain memory of past pathogen encounters.

Question 1

Which factor has the most significant influence on the oxygen dissociation curve?

Accepted Answer

2,3-BPG

Answer

pH

Answer

Temperature

Answer

All of these

Question 2

What is the mechanism by which hemolysis causes jaundice?

Accepted Answer

Increased production of unconjugated bilirubin due to hemolysis

Answer

Increased production of conjugated bilirubin due to liver dysfunction

Answer

Decreased conjugation of bilirubin in the liver

Answer

Increased reabsorption of bilirubin in the intestines

Question 3

A 45-year-old patient with chronic anemia presents with fatigue, dyspnea, and visible cyanosis. Recent blood tests show hemoglobin of 7 g/dL. Which of the following best explains the presence of cyanosis in this patient?

Accepted Answer

Increased deoxyhemoglobin concentration

Answer

Methemoglobinemia

Answer

Peripheral vasoconstriction

Answer

Decreased oxygen-carrying capacity of blood

Question 4

Which of the following best describes the function of hemoglobin in the blood?

Accepted Answer

Transport of oxygen

Answer

Buffering blood pH

Answer

Clot formation

Answer

Immune response

Question 5

A blood grouping test shows clumping with Anti-A serum, clumping with Anti-B serum, and no clumping in the control. What blood group does this indicate?

Accepted Answer

AB

Answer

A

Answer

B

Answer

O

Question 6

What is the lower limit of normal hemoglobin (Hb) value for a non-pregnant adult female in grams per deciliter (gm/dl)?

Accepted Answer

12 gm/dl

Answer

10 gm/dl

Answer

11 gm/dl

Answer

15.8 gm/dl

Question 7

Which pathway is primarily initiated by tissue factor in the coagulation process?

Accepted Answer

Extrinsic pathway

Answer

Contact pathway

Answer

Intrinsic pathway

Answer

Common pathway

Question 8

What does tissue factor activate?

Accepted Answer

Proconvertin

Answer

Prothrombin

Answer

Hageman factor

Answer

Labile factor

Question 9

Which test is used for both intrinsic and common clotting pathways?

Accepted Answer

Partial thromboplastin time

Answer

Thrombin time

Answer

Ristocetin agglutination test

Answer

FDPs

Question 10

Which type of white blood cell is responsible for 'remembering' previous encounters with pathogens?

Accepted Answer

Lymphocytes

Answer

Basophils

Answer

Eosinophils

Answer

Neutrophils

Blood and Immunity — MCQs

Blood and Immunity — MCQs

On this page

Practice by Chapter

Want unlimited practice?